Sandy Liebhard

Sandy A. Liebhard, a founding partner at Bernstein Liebhard LLP, has successfully represented plaintiffs in complex litigations for more than 20 years. As dedicated consumer advocates, Mr. Liebhard and his fellow attorneys have taken on some of the largest corporate interest in the nation in cases involving dangerous pharmaceuticals, faulty medical devices and defective consumer products. As an author for RXInuryHelp.com, Mr. Liebhard has written extensively on the litigation involving proton pump inhibitors (Nexium, Prilosec, PrevAcid, etc.) and kidney injuries; Risperdal and gynecomastia; the Bair Hugger forced air warming blanket; talcum powder and ovarian cancer; transvaginal mesh; power morcellators; defective hip implants; and more.

Mr. Liebhard is a 1988 graduate of Brooklyn Law School. He is admitted to the Bar of the State of New York, as well as the United States District Courts for the Southern and Eastern Districts of New York.


Generic Valsartan Manufacturers Cited for Quality Control Problems

The U.S. Food & Drug Administration’s (FDA) recent decision to approve generic valsartan manufactured by two overseas pharmaceutical companies is coming under scrutiny, following reports of serious quality control issues at their manufacturing facilities in India. Approvals Came Amid Serious … Continue reading

Kenneth Feinberg Tapped for Monsanto Roundup Mediation

A federal judge has asked attorney Kenneth Feinberg to mediate talks aimed at settling thousands of Monsanto Roundup lawsuits that blame glyphosate for cancer. U.S. District Judge Vince Chhabria of the Northern District of California appointed Feinberg after the parties’ … Continue reading

Military Earplugs Lawsuits, Other Litigation Costs Weigh on 3M Company

The 3M Company has faced a wave of personal injury lawsuits in recent years, and it now looks like the Minnesota-based manufacturer’s legal woes are beginning to impact its bottom line. Legal Costs Reflected in 3M Company Earnings The lawsuits … Continue reading

New York City Jury Hits Johnson & Johnson with $25 Million Talcum Powder Verdict

A jury in New York City has awarded $25 million to a woman who claimed asbestos-tainted Baby Powder caused her cancer. Plaintiff Began Using Baby Powder at Age of 8 Yesterday’s talcum powder verdict only includes compensatory damages. The same … Continue reading

Monsanto Data Collection Scandal Spreads to More European Countries

Bayer AG’s Monsanto troubles have moved beyond costly Roundup cancer lawsuits. A little more than a week after the German conglomerate acknowledged a Monsanto data collection effort that targeted journalists, researchers, and other critics in France, the scandal has ensnared … Continue reading

European Regulators Impose Xeljanz Restrictions Amid Safety Worries

Drug regulators in the European Union have decided to limit the use of Xeljanz, months after a post-market safety study flagged pulmonary embolism and a higher death rate as possible safety signals for rheumatoid arthritis patients taking a 10mg-twice daily … Continue reading

Class I Recall for Ethicon Surgical Staplers Following Injury, Malfunction Reports

Johnson & Johnson’s Ethicon, Inc. subsidiary has recalled thousands of internal surgical staplers, following reports that they misfired or failed to completely form staples during procedures. The U.S. Food & Drug Administration (FDA) has granted the surgical stapler recall Class … Continue reading

Federal Judge Refuses to Nix Lawsuit Over Gilead HIV Drugs

A federal judge has refused to dismiss a lawsuit that claims Gilead Sciences, Inc. purposely delayed development of a safer HIV drug for years, merely to protect profits from sales of tenofovir disoproxil fumarate, or TDF. History of Gilead HIV … Continue reading

Study Links Human Liver Disease to Glyphosate Exposure

Newly published research is pointing to yet another possible consequence of glyphosate exposure, an increased risk of liver disease. Previous Research Suggests Glyphosate Exposure Increases Cancer Risks Glyphosate, the active ingredient in Monsanto Roundup, has already been declared a probable … Continue reading

Pennsylvania Supreme Court to Hear Risperdal Statute of Limitations Arguments

Attorneys for two Risperdal gynecomastia plaintiffs will appear before the Pennsylvania Supreme Court in Harrisburg today, where they’ll seek reversal of a lower court ruling that dismissed their clients’ cases as time-barred. The Court’s ultimate decision on the Risperdal statute … Continue reading

Follow Us

RXInjuryHelp.com on Google+  RXInjuryHelp.com on Facebook  RXInjuryHelp.com on LinkedIn  RXInjuryHelp.com on Twitter  RXInjuryHelp.com on YouTube  RXInjuryHelp.com on Pinterest

Skip to content